These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19498050)

  • 1. The role of serotonin in the pathophysiology of depression: as important as ever.
    Nemeroff CB; Owens MJ
    Clin Chem; 2009 Aug; 55(8):1578-9. PubMed ID: 19498050
    [No Abstract]   [Full Text] [Related]  

  • 2. [[Pathophysiology and treatment of depression: a review of PET imaging of serotonin transporter].
    Matsumoto R; Suhara T
    Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):464-8. PubMed ID: 18079596
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.
    Owens MJ; Nemeroff CB
    Clin Chem; 1994 Feb; 40(2):288-95. PubMed ID: 7508830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants and the serotonin uptake in platelets.
    Lingjaerde O
    Acta Psychiatr Scand Suppl; 1980; 280():111-9. PubMed ID: 6996427
    [No Abstract]   [Full Text] [Related]  

  • 5. From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.
    Brandl EJ; Walter H
    Pharmacogenomics; 2017 Jul; 18(10):927-930. PubMed ID: 28639501
    [No Abstract]   [Full Text] [Related]  

  • 6. Untangling depression and anxiety: clinical challenges.
    Keller MB; Krystal JH; Hen R; Neumeister A; Simon NM
    J Clin Psychiatry; 2005 Nov; 66(11):1477-84. PubMed ID: 16420087
    [No Abstract]   [Full Text] [Related]  

  • 7. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.
    Köhler S; Cierpinsky K; Kronenberg G; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):13-22. PubMed ID: 26464458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography.
    Spies M; James GM; Berroterán-Infante N; Ibeschitz H; Kranz GS; Unterholzner J; Godbersen M; Gryglewski G; Hienert M; Jungwirth J; Pichler V; Reiter B; Silberbauer L; Winkler D; Mitterhauser M; Stimpfl T; Hacker M; Kasper S; Lanzenberger R
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):145-153. PubMed ID: 29045739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography.
    Oquendo MA; Hastings RS; Huang YY; Simpson N; Ogden RT; Hu XZ; Goldman D; Arango V; Van Heertum RL; Mann JJ; Parsey RV
    Arch Gen Psychiatry; 2007 Feb; 64(2):201-8. PubMed ID: 17283287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls.
    Neumeister A; Hu XZ; Luckenbaugh DA; Schwarz M; Nugent AC; Bonne O; Herscovitch P; Goldman D; Drevets WC; Charney DS
    Arch Gen Psychiatry; 2006 Sep; 63(9):978-86. PubMed ID: 16953000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial.
    Kato M; Nonen S; Serretti A; Tetsuo S; Takekita Y; Azuma J; Kinoshita T
    J Clin Psychopharmacol; 2013 Feb; 33(1):131-2. PubMed ID: 23288236
    [No Abstract]   [Full Text] [Related]  

  • 13. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of some tricyclic antidepressive drugs on the uptake of 5-hydroxytryptamine by rat blood platelets.
    Buczko W; De Gaetano G; Garattini S
    J Pharm Pharmacol; 1974 Oct; 26(10):814-5. PubMed ID: 4156540
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.
    Helton SG; Lohoff FW
    Pharmacogenomics; 2015; 16(5):541-53. PubMed ID: 25916524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression and ischemic heart disease: what have we learned so far and what must we do in the future?
    Jiang W; Glassman A; Krishnan R; O'Connor CM; Califf RM
    Am Heart J; 2005 Jul; 150(1):54-78. PubMed ID: 16084151
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of serotonin in depression.
    Meltzer HY
    Ann N Y Acad Sci; 1990; 600():486-99; discussion 499-500. PubMed ID: 2252328
    [No Abstract]   [Full Text] [Related]  

  • 18. [PET study. Winter blues: serotonin transporter is responsible].
    Müller T
    MMW Fortschr Med; 2014 Nov; 156(19):26. PubMed ID: 25510010
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology.
    Bruce KR; Steiger H; Ng Ying Kin NM; Israel M
    Psychiatry Res; 2006 Jun; 142(2-3):225-32. PubMed ID: 16697471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dopamine and norepinephrine in depression and antidepressant treatment.
    Nutt DJ
    J Clin Psychiatry; 2006; 67 Suppl 6():3-8. PubMed ID: 16848670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.